Levine Cancer Institute
Charlotte, NC
HER2-positive Breast Cancer and COVID-19
Patient Jocelyn Mueller and oncologist Julia Fisher, M.D., describe some of the adjustments that had to be made to Jocelyn’s treatment for HER2-positive breast cancer due to the COVID-19 pandemic.
Read More
The Importance of Support Networks for HER2-positive Breast Cancer
Julie Fisher, M.D., has a conversation with patient Jocelyn Mueller about the importance of good support networks when living with HER2-positive breast cancer.
The Patient’s Perspective on how Treatment for HER2-positive Breast Cancer impacts Daily Life
Jocelyn Mueller details how chemotherapy treatments have affected her daily life and her decision to receive treatment through a port.
Assessing HER2-positive Breast Cancer Treatment Responses and Managing Side Effects
Julie Fisher, MD, explains how she assesses HER2-positive breast cancer patients for treatment response, what side-effects can occur and how they can be managed.
Receiving Treatment for HER2-positive Breast Cancer: The Patient Experience
Jocelyn Mueller describes the preoperative treatments she has received for HER2-positive breast cancer, and the questions she had for her medical care team.
HER2-positive Breast Cancer: Post-Operative Therapies
Dr. Julie Fisher details the therapies used for HER2-positive breast cancer in the post-operative setting, including newly available treatment options, and reviews data supporting the choice of therapy for each patient.
HER2-positive Breast Cancer: Pre-operative Therapies
Dr. Julie Fisher, an expert oncologist, describes the range of treatment options for HER2-positive breast cancer in the pre-operative setting.
Being Diagnosed With HER2-positive Breast Cancer
Jocelyn Mueller, a patient with HER2-positive breast cancer, explains how she received her diagnosis.
An Overview of HER2-positive Breast Cancer
Julie Fisher, MD, gives a brief overview of HER2-positive breast cancer and the tests available for diagnosis.